Company Badge
USPTO Data Jan 1 1976 - Oct 20 2026
8 Patents
#274 in Cambridge, MA
#2,101 in Massachusetts
#35,941 in US
Fulcrum Therapeutics, Inc.
Forward Citations = 13
17 inventors:
Cambridge, MA, United States of America
Fulcrum Therapeutics, Inc.
EPO Patents = 1
Trademarks = 7
Forward Citations = 13
Loading Chart...
Loading Chart...
17 inventors (with patents filed for the assignee):
Owen Brendan Wallace (7 out of 7 patents)
Lorin A Thompson, Iii (7 out of 7 patents)
Luis Gustavo Alejandro Rojas Soto (4 out of 4 patents)
4. Lucienne V Ronco (4 out of 4 patents)
5. Ning Shen (4 out of 4 patents)
6. Alan Scott Robertson (4 out of 4 patents)
7. Aaron Nakwon Chang (4 out of 4 patents)
8. Angela Marie Cacace (4 out of 13 patents)
9. Qingyi Li (3 out of 9 patents)
10. Peter B Rahl (3 out of 9 patents)
11. Ivan Viktorovich Efremov (3 out of 25 patents)
12. Steven Kazmirski (3 out of 3 patents)
13. Shawn Donald Johnstone (3 out of 3 patents)
14. Feng Zhou (3 out of 3 patents)
15. Michael R Green (1 out of 28 patents)
8 patents:
Company Overview
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on unlocking gene control mechanisms to develop small molecule therapies for serious genetic diseases. The company's proprietary product engine integrates insights from chromatin biology and transcriptional regulation to identify and drug master control nodes within disease-associated genes.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fulcrum Therapeutics, Inc.. Retrieved from https://idiyas.com/company/fulcrum-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]